Teva Pharmaceutical Industries Limited TEVJF
38.98 USD 0.00 (+0.00%)
Regular-session close
32.89 Day range 38.98
14.32 52-week range 39.70
- YTD
- +36.25%
- 1 year
- +118.99%
Included in Essentials and up
Sign in to see Fair value
Discounted cash flow estimates against the price, and the P/E against its industry and sector.
Included in Essentials and up
Sign in to see Head count and owner earnings
Employees by annual report and the cash the business earns for its owners.
Included in Essentials and up
Sign in to see P/E against peers
The price to earnings ratio beside the closest competitors and their median.
Included in Essentials and up
Sign in to see Cash flow and returns
How profit turns into free cash flow, and the returns on equity, assets and capital.
Financial health
Altman Z-Score
0.89 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E 23.3×
P/S 1.9×
P/B 4.1×
P/FCF 12.8×
EV/EBITDA 8.7×
EV/Sales 2.7×
FCF Yield 7.8%
Profitability
Gross Margin 51.8%
Operating Margin 12.5%
Net Margin 8.9%
ROE 19.3%
ROIC 7.4%
ROA 3.7%
Growth (YoY)
Revenue 4.3%
Operating Income 811.9%
EPS (diluted) 183.4%
Free Cash Flow 241.4%
Financial Health
Current Ratio 1.0×
Quick Ratio 0.8×
Debt / Equity 2.2×
Net Debt / EBITDA 2.5×
Interest Coverage 2.1×
Dividends
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31
